We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AFLURIA QUAD (Seqirus Pty Ltd)
Product name
AFLURIA QUAD
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
200 working days (255)
Active ingredients
inactivated quadrivalent influenza vaccine (split virion)
Registration type
EOI
Indication
AFLURIA QUAD is now also indicated for the prevention of influenza caused by Influenza Virus, Types A and B contained in the vaccine, in persons aged 5-17 years.